Glenmark Pharmaceuticals Launches Olanzapine for Injection
() -- The US-based unit of Glenmark Pharmaceuticals (NSE:GLENMARK, BOM:532296) has launched its Olanzapine for Injection, 10 mg/vial, single-dose vial, according to a Monday filing to the Indian stock exchanges. Glenmark's Olanzapine for injection is bioequivalent and therapeutically equivalent to Cheplapharm Registrat